HK Stock MarketDetailed Quotes

SIHUAN PHARM (00460)

Watchlist
  • 1.220
  • -0.030-2.40%
Not Open May 6 16:07 CST
11.16BMarket Cap55.45P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

SIHUAN PHARM (00460) Revenue Breakdown Overview

By Business/Source

Currency:CNY
2025/FY
Stock NameRevenueRatio
医美产品1.49B56.73%
仿制药956.32M36.53%
创新药及其他药品176.43M6.74%

By Product

Currency:CNY
2025/FY
Stock NameRevenueRatio
医美产品1.49B56.73%
仿制药956.32M36.53%
创新药及其他药品176.43M6.74%

By Country/Region

Currency:CNY
2025/FY
Stock NameRevenueRatio
The mainland of China2.6B99.49%
United States of America13.1M0.50%
Other342K0.01%

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Petroleum
No. Symbol 20D % Chg
Sample Name
Sample Code
 +8.45%
Sample Name
Sample Code
 +4.80%
Sample Name
Sample Code
 +3.86%
4
CNOOC
00883
+3.77%
5
SINOPEC CORP
00386
+2.61%
View More
No. Symbol 20D % Chg
Sample Name
Sample Code
 +61.02%
Sample Name
Sample Code
 +51.07%
Sample Name
Sample Code
 +40.94%
4
Business-intelligence Of Oriental Nations Corporation
300166
+33.12%
5
Emdoor Information
001314
+32.98%
View More
China and the US begin implementing the Kuala Lumpur economic and trade consultation consensus.
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More
[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?
"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"

- No more -